Dusp4 silencing enhances the sensitivity of breast cancer cells to doxorubicin through the activation of the jnk/c-jun signalling pathway

HIGHLIGHTS

• who: Mashael S. Al-Mutairi and Hany O. Habashy from the Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Health Science Center, Kuwait University, Safat POBox, Kuwait have published the research work: DUSP4 Silencing Enhances the Sensitivity of Breast Cancer Cells to Doxorubicin through the Activation of the JNK/c-Jun Signalling Pathway, in the Journal: Molecules 2022, 27, x FOR PEER (Figure REVIEW 8C). of /2022/
• what: In this study the possible involvement of MKP-2 in Dox-induced was investigated in breast cancer cells. The authors show that MKP-2 silencing . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.